Companies Plan To Study Diabetes Drug In Heart Failure Population

–New attention paid to the intersection of heart failure and diabetes Boehringer Ingelheim and Eli Lilly announced on Wednesday that they were planning two separate outcomes trials to test the effect of the diabetes drug empagliflozin (Jardiance) in patients with chronic heart failure. The trials herald a remarkable shift in emphasis, since there have been...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Diabetes Heart Failure People, Places & Events empagliflozin Jardiance Source Type: blogs